419 related articles for article (PubMed ID: 34298959)
1. Gene Transcription as a Therapeutic Target in Leukemia.
Khamidullina AI; Varlamova EA; Hammoud NA; Yastrebova MA; Bruter AV
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298959
[TBL] [Abstract][Full Text] [Related]
2. The role of homeobox genes in normal hematopoiesis and hematological malignancies.
van Oostveen J; Bijl J; Raaphorst F; Walboomers J; Meijer C
Leukemia; 1999 Nov; 13(11):1675-90. PubMed ID: 10557039
[TBL] [Abstract][Full Text] [Related]
3. Hematological malignancies: disease pathophysiology of leukemic stem cells.
Ramdass B; Chowdhary A; Koka PS
J Stem Cells; 2013; 8(3-4):151-87. PubMed ID: 24699024
[TBL] [Abstract][Full Text] [Related]
4. Role of RUNX1 in hematological malignancies.
Sood R; Kamikubo Y; Liu P
Blood; 2017 Apr; 129(15):2070-2082. PubMed ID: 28179279
[TBL] [Abstract][Full Text] [Related]
5. Cellular signaling and epigenetic regulation of gene expression in leukemia.
Gowda C; Song C; Ding Y; Iyer S; Dhanyamraju PK; McGrath M; Bamme Y; Soliman M; Kane S; Payne JL; Dovat S
Adv Biol Regul; 2020 Jan; 75():100665. PubMed ID: 31623972
[TBL] [Abstract][Full Text] [Related]
6. Autophagy and Metabolism in Normal and Malignant Hematopoiesis.
Stergiou IE; Kapsogeorgou EK
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445246
[TBL] [Abstract][Full Text] [Related]
7. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor.
Ying J; Li H; Chen YW; Srivastava G; Gao Z; Tao Q
Blood; 2007 Dec; 110(12):4130-2. PubMed ID: 18024799
[No Abstract] [Full Text] [Related]
8. The interplay of leukemia cells and the bone marrow microenvironment.
Duarte D; Hawkins ED; Lo Celso C
Blood; 2018 Apr; 131(14):1507-1511. PubMed ID: 29487069
[TBL] [Abstract][Full Text] [Related]
9. Emerging targets for hematological malignancies.
Cilloni D; Frassoni F; Saglio G
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146
[TBL] [Abstract][Full Text] [Related]
10. The Dual Role of ROS in Hematological Malignancies: Stem Cell Protection and Cancer Cell Metastasis.
Samimi A; Khodayar MJ; Alidadi H; Khodadi E
Stem Cell Rev Rep; 2020 Apr; 16(2):262-275. PubMed ID: 31912368
[TBL] [Abstract][Full Text] [Related]
11. The role of the GATA2 transcription factor in normal and malignant hematopoiesis.
Vicente C; Conchillo A; García-Sánchez MA; Odero MD
Crit Rev Oncol Hematol; 2012 Apr; 82(1):1-17. PubMed ID: 21605981
[TBL] [Abstract][Full Text] [Related]
12. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation changes in hematologic malignancies: biologic and clinical implications.
Issa JP; Baylin SB; Herman JG
Leukemia; 1997 Mar; 11 Suppl 1():S7-11. PubMed ID: 9130685
[TBL] [Abstract][Full Text] [Related]
14. [Autophagy, a key player in leukemogenesis and a therapeutic target in hematopoietic malignancies].
Jacquel A; Luciano F; Puissant A; Robert G; Auberger P
Med Sci (Paris); 2017 Mar; 33(3):226-229. PubMed ID: 28367807
[No Abstract] [Full Text] [Related]
15. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
Alonso S; Jones RJ; Ghiaur G
Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
[TBL] [Abstract][Full Text] [Related]
16. Familial childhood leukemia cluster with multiple aggressive early-onset hematological malignancies.
Swinney RM; Wall DA; Thomas PJ; Grimley MS; Taylor C; Tomlinson GE
Leuk Lymphoma; 2006 May; 47(5):930-2. PubMed ID: 16753883
[No Abstract] [Full Text] [Related]
17. Reprogramming cell death: BCL2 family inhibition in hematological malignancies.
Scarfò L; Ghia P
Immunol Lett; 2013; 155(1-2):36-9. PubMed ID: 24095849
[TBL] [Abstract][Full Text] [Related]
18. Double sword role of EZH2 in leukemia.
Safaei S; Baradaran B; Hagh MF; Alivand MR; Talebi M; Gharibi T; Solali S
Biomed Pharmacother; 2018 Feb; 98():626-635. PubMed ID: 29289837
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency.
Ikeda K; Ueda T; Yamasaki N; Nakata Y; Sera Y; Nagamachi A; Miyama T; Kobayashi H; Takubo K; Kanai A; Oda H; Wolff L; Honda Z; Ichinohe T; Matsubara A; Suda T; Inaba T; Honda H
Sci Rep; 2016 Jul; 6():29454. PubMed ID: 27432459
[TBL] [Abstract][Full Text] [Related]
20. Polycomb complexes in normal and malignant hematopoiesis.
Di Carlo V; Mocavini I; Di Croce L
J Cell Biol; 2019 Jan; 218(1):55-69. PubMed ID: 30341152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
